{"id":"https://openalex.org/W7169844535","doi":"https://doi.org/10.1158/1557-3265.d32026-a020","title":"Abstract A020: Engineering developability of anti-CD3 scFv-based multispecific T-cell engagers","display_name":"Abstract A020: Engineering developability of anti-CD3 scFv-based multispecific T-cell engagers","publication_year":2026,"publication_date":"2026-07-21","ids":{"openalex":"https://openalex.org/W7169844535","doi":"https://doi.org/10.1158/1557-3265.d32026-a020"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.d32026-a020","doi":"https://doi.org/10.1158/1557-3265.d32026-a020","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.d32026-a020","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112540180","display_name":"Robert Pejchal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Pejchal","raw_affiliation_strings":["1Adimab LLC, Lebanon, NH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Adimab LLC, Lebanon, NH","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021582152","display_name":"Kevin Schutz","orcid":"https://orcid.org/0000-0002-5739-1554","observed_orcids":["https://orcid.org/0000-0002-5739-1554"]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Schutz","raw_affiliation_strings":["1Adimab LLC, Lebanon, NH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Adimab LLC, Lebanon, NH","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020741638","display_name":"Michael B. Battles","orcid":"https://orcid.org/0000-0002-5321-7460","observed_orcids":["https://orcid.org/0000-0002-5321-7460"]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Battles","raw_affiliation_strings":["1Adimab LLC, Lebanon, NH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Adimab LLC, Lebanon, NH","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141286921","display_name":"John Bukowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Bukowski","raw_affiliation_strings":["1Adimab LLC, Lebanon, NH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Adimab LLC, Lebanon, NH","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028683646","display_name":"Olivia J. Scheideler","orcid":"https://orcid.org/0000-0001-9366-6992","observed_orcids":["https://orcid.org/0000-0001-9366-6992"]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olivia Scheideler","raw_affiliation_strings":["1Adimab LLC, Lebanon, NH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Adimab LLC, Lebanon, NH","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106280598","display_name":"Allie Karakosta LeMay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allie LeMay","raw_affiliation_strings":["1Adimab LLC, Lebanon, NH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Adimab LLC, Lebanon, NH","institution_ids":["https://openalex.org/I4210161061"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210161061"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"14_Supplement","first_page":"A020","last_page":"A020"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-cd3-scfv","display_name":"anti-CD3 scFv","score":0.9210000038146973},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.8629999756813049},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.5379999876022339},{"id":"https://openalex.org/keywords/antibody-aggregation","display_name":"antibody aggregation","score":0.44699999690055847},{"id":"https://openalex.org/keywords/ph-induced-aggregation","display_name":"pH-induced aggregation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/hydrophobicity","display_name":"hydrophobicity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/valence","display_name":"valence","score":0.671999990940094},{"id":"https://openalex.org/keywords/disulfide-bond-engineering","display_name":"disulfide bond engineering","score":0.6740000247955322},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.6809999942779541},{"id":"https://openalex.org/keywords/developability","display_name":"developability","score":0.6510000228881836},{"id":"https://openalex.org/keywords/antibody-stability","display_name":"antibody stability","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C2776235265","wikidata":"https://www.wikidata.org/wiki/Q18392052","display_name":"Fragment (logic)","level":2,"score":0.6653000116348267},{"id":"https://openalex.org/C2776967038","wikidata":"https://www.wikidata.org/wiki/Q290671","display_name":"Single-chain variable fragment","level":4,"score":0.5730000138282776},{"id":"https://openalex.org/C27256138","wikidata":"https://www.wikidata.org/wiki/Q1230226","display_name":"Disulfide bond","level":2,"score":0.5511000156402588},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5483999848365784},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5178999900817871},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4629000127315521},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4318999946117401},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42669999599456787},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.3628000020980835},{"id":"https://openalex.org/C139007053","wikidata":"https://www.wikidata.org/wiki/Q1412952","display_name":"Valency","level":2,"score":0.3262999951839447},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30649998784065247},{"id":"https://openalex.org/C125411270","wikidata":"https://www.wikidata.org/wiki/Q18653","display_name":"Encoding (memory)","level":2,"score":0.2782999873161316},{"id":"https://openalex.org/C2778805511","wikidata":"https://www.wikidata.org/wiki/Q1713","display_name":"Citation","level":2,"score":0.26910001039505005},{"id":"https://openalex.org/C2776321320","wikidata":"https://www.wikidata.org/wiki/Q857525","display_name":"Annotation","level":2,"score":0.2689000070095062},{"id":"https://openalex.org/C2778112365","wikidata":"https://www.wikidata.org/wiki/Q3511065","display_name":"Sequence (biology)","level":2,"score":0.2554999887943268},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.2533000111579895},{"id":"https://openalex.org/C2778220771","wikidata":"https://www.wikidata.org/wiki/Q1522579","display_name":"Substitution (logic)","level":2,"score":0.2524000108242035}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.d32026-a020","doi":"https://doi.org/10.1158/1557-3265.d32026-a020","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.d32026-a020","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2000246970","https://openalex.org/W4366350949","https://openalex.org/W26760683","https://openalex.org/W2101341126","https://openalex.org/W2154543415","https://openalex.org/W2235519817","https://openalex.org/W2889903561","https://openalex.org/W2081603678","https://openalex.org/W2393299820","https://openalex.org/W2090022234"],"abstract_inverted_index":{"Abstract":[0],"Multispecific":[1],"T-cell":[2,198],"engager":[3],"antibody":[4,38],"assembly":[5,109],"requires":[6],"solutions":[7],"to":[8,30,43,143,165,170],"avoid":[9],"non-cognate":[10],"chain-pairing.":[11],"The":[12],"single-chain":[13],"fragment":[14,87],"variable":[15],"(scFv)":[16],"format":[17,42],"solves":[18],"the":[19,40,59,78,81,121,127,137],"LC":[20],"pairing":[21],"problem,":[22],"however":[23],"biophysical":[24,145],"properties":[25,100,146],"are":[26,163],"usually":[27],"significantly":[28,44,171],"inferior":[29],"Fab-based":[31,105],"molecules.":[32],"Here":[33],"we":[34,135],"engineer":[35],"an":[36],"anti-CD3":[37,95,195],"in":[39],"scFv":[41,96,124,148],"improve":[45,99,144,172],"aggregation":[46,53],"and":[47,55,72,77,152,155,158,169,207],"stability,":[48],"including":[49],"low":[50],"pH":[51],"stress-induced":[52],"resistance,":[54],"hydrophobicity.":[56],"We":[57,91],"describe":[58,136],"impact":[60],"of":[61,80,101,110,139,147,150,174,194,203],"design":[62],"parameters,":[63],"such":[64],"as":[65,86],"varying":[66],"valency":[67],"(e.g.":[68],"1":[69,71],"+":[70,74],"2":[73],"2),":[75],"topology,":[76],"sequence":[79],"anti-tumor":[82],"associated":[83],"antigen":[84],"Fv":[85],"antigen-binding":[88],"(Fab)":[89],"format.":[90],"observe":[92],"that":[93],"stabilized":[94],"not":[97,118],"only":[98],"two":[102],"clinical":[103,113],"CD20":[104,114],"multispecifics":[106],"but":[107],"rescue":[108],"a":[111],"third":[112],"molecule,":[115],"which":[116],"did":[117],"produce":[119],"with":[120,126],"parental,":[122],"unmodified":[123],"or":[125],"industry":[128],"standard":[129],"engineered":[130],"disulfide":[131],"bond":[132],"VH44-VK100.":[133],"Lastly,":[134],"ability":[138],"these":[140],"stabilizing":[141],"mutations":[142],"regardless":[149],"VH":[151],"VK":[153],"germline,":[154],"CDR":[156],"H3":[157],"L3":[159],"sequence.":[160],"Our":[161],"findings":[162],"expected":[164],"be":[166],"broadly":[167],"applicable":[168],"outcomes":[173],"scFv-based":[175,196],"multispecific":[176,197],"production.":[177],"Citation":[178],"Format:":[179],"Robert":[180],"Pejchal,":[181],"Kevin":[182],"Schutz,":[183],"Michael":[184],"Battles,":[185],"John":[186],"Bukowski,":[187],"Olivia":[188],"Scheideler,":[189],"Allie":[190],"LeMay.":[191],"Engineering":[192],"developability":[193],"engagers":[199],"[abstract].":[200],"In:":[201],"Proceedings":[202],"AACR":[204],"Drug":[205],"Discovery":[206],"Development":[208],"(AACR":[209],"D3)":[210],"Conference;":[211],"2026":[212],"Jul":[213],"21-24;":[214],"Boston,":[215],"MA.":[216],"Philadelphia":[217],"(PA):":[218],"AACR;":[219],"Clin":[220],"Cancer":[221],"Res":[222],"2026;32(14_Suppl):Abstract":[223],"nr":[224],"A020.":[225]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2026-07-22T00:00:00"}